Form Bio Co. Ltd. Financial Flexibility Index
Form Bio Co. Ltd. financial flexibility index. Form Bio Co. Ltd. (377220) has a Financial Flexibility Index of -0.03x as of June 2026. Free cash flow of ₩-1.38 Billion (operating CF ₩-1.40 Billion minus capex ₩18.38 Million) represents 0% of total liabilities (₩39.64 Billion). See free cash flow generation of Form Bio Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Form Bio Co. Ltd. (2019–2025)
Financial flexibility index of Form Bio Co. Ltd. from 2019 to 2025. Historical Financial Flexibility Index trend for Form Bio Co. Ltd. across 7 annual periods. Check cash flow quality index of Form Bio Co. Ltd. to evaluate the quality of earnings relative to operating cash generation.
Form Bio Co. Ltd. Financial Flexibility Index by Year (2019–2025)
Form Bio Co. Ltd. financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Form Bio Co. Ltd.. For the full cash flow conversion analysis, see 377220 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | ₩-8.81 Billion | ₩-10.07 Billion | ₩39.11 Billion | ▲ +47.7% |
| 2024 | -0.43x | ₩-13.81 Billion | ₩-14.70 Billion | ₩32.07 Billion | ▼ -130.3% |
| 2023 | -0.19x | ₩-4.15 Billion | ₩-20.85 Billion | ₩22.19 Billion | ▼ -108.3% |
| 2022 | 2.24x | ₩13.16 Billion | ₩-2.02 Billion | ₩5.87 Billion | ▲ +168.9% |
| 2021 | 0.83x | ₩10.00 Billion | ₩-1.17 Billion | ₩11.99 Billion | ▼ -19.9% |
| 2020 | 1.04x | ₩22.24 Billion | ₩15.61 Billion | ₩21.35 Billion | ▲ +350.6% |
| 2019 | 0.23x | ₩7.96 Billion | ₩5.68 Billion | ₩34.45 Billion | — |